Importantly, after RA FLS were treated with various inflammatory factors in vitro, such as IL-6, IL-1β, IL-17A, TNF-α, IFN-γ, and LPS, western blot results showed that BMP3 expression was decreased to different degrees (Figure 1F). The gene discussed is IL17A; the disease is rheumatoid arthritis.